https://www.selleckchem.com/pr....oducts/Temsirolimus.
37, 95% CI = 1.01-1.84, P = 0.04) graft survival. WL grafts were less associated with retransplantation (OR = 0.57; 95% CI = 0.41-0.80; P less then 0.01), vascular complications (OR = 0.53, 95% CI = 0.38-0.74, P less then 0.01) and biliary complications (OR = 0.67; 95% CI = 0.47-0.95; P = 0.03). Considering ERLT as major Extended Donor Criteria is justified because ERL grafts are associated with vasculobiliary complications and the need for retransplantation, and have a negative influence on graft survival.Generally, floral charact